Literature DB >> 20570966

Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.

Dermot P B McGovern1, Michelle R Jones, Kent D Taylor, Kristin Marciante, Xiaofei Yan, Marla Dubinsky, Andy Ippoliti, Eric Vasiliauskas, Dror Berel, Carrie Derkowski, Deb Dutridge, Phil Fleshner, David Q Shih, Gil Melmed, Emebet Mengesha, Lily King, Sheila Pressman, Talin Haritunians, Xiuqing Guo, Stephan R Targan, Jerome I Rotter.   

Abstract

Genetic variation in both innate and adaptive immune systems is associated with Crohn's disease (CD) susceptibility, but much of the heritability to CD remains unknown. We performed a genome-wide association study (GWAS) in 896 CD cases and 3204 healthy controls all of Caucasian origin as defined by multidimensional scaling. We found supportive evidence for 21 out of 40 CD loci identified in a recent CD GWAS meta-analysis, including two loci which had only nominally achieved replication (rs4807569, 19p13; rs991804, CCL2/CCL7). In addition, we identified associations with genes involved in tight junctions/epithelial integrity (ASHL, ARPC1A), innate immunity (EXOC2), dendritic cell biology [CADM1 (IGSF4)], macrophage development (MMD2), TGF-beta signaling (MAP3K7IP1) and FUT2 (a physiological trait that regulates gastrointestinal mucosal expression of blood group A and B antigens) (rs602662, P=3.4x10(-5)). Twenty percent of Caucasians are 'non-secretors' who do not express ABO antigens in saliva as a result of the FUT2 W134X allele. We demonstrated replication in an independent cohort of 1174 CD cases and 357 controls between the four primary FUT2 single nucleotide polymorphisms (SNPs) and CD (rs602662, combined P-value 4.90x10(-8)) and also association with FUT2 W143X (P=2.6x10(-5)). Further evidence of the relevance of this locus to CD pathogenesis was demonstrated by the association of the original four SNPs and CD in the recently published CD GWAS meta-analysis (rs602662, P=0.001). These findings strongly implicate this locus in CD susceptibility and highlight the role of the mucus layer in the development of CD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570966      PMCID: PMC2916706          DOI: 10.1093/hmg/ddq248

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  76 in total

1.  A tail strength measure for assessing the overall univariate significance in a dataset.

Authors:  Jonathan Taylor; Robert Tibshirani
Journal:  Biostatistics       Date:  2005-12-06       Impact factor: 5.899

Review 2.  Whole-genome genotyping.

Authors:  Kevin L Gunderson; Frank J Steemers; Hongi Ren; Pauline Ng; Lixin Zhou; Chan Tsan; Weihua Chang; Dave Bullis; Joe Musmacker; Christine King; Lori L Lebruska; David Barker; Arnold Oliphant; Kenneth M Kuhn; Richard Shen
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus.

Authors:  D M Nielsen; M G Ehm; B S Weir
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

5.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

6.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

7.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

Authors:  P Rutgeerts; M Hiele; K Geboes; M Peeters; F Penninckx; R Aerts; R Kerremans
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

8.  Binding specificity of Lactobacillus to glycolipids.

Authors:  K Yamamoto; T Miwa; H Taniguchi; T Nagano; K Shimamura; T Tanaka; H Kumagai
Journal:  Biochem Biophys Res Commun       Date:  1996-11-01       Impact factor: 3.575

9.  Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype.

Authors:  R J Kelly; S Rouquier; D Giorgi; G G Lennon; J B Lowe
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

10.  Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats.

Authors:  H C Rath; J S Ikeda; H J Linde; J Schölmerich; K H Wilson; R B Sartor
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

View more
  156 in total

1.  Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype.

Authors:  Philipp Rausch; Ateequr Rehman; Sven Künzel; Robert Häsler; Stephan J Ott; Stefan Schreiber; Philip Rosenstiel; Andre Franke; John F Baines
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-08       Impact factor: 11.205

2.  Metagenomics and personalized medicine.

Authors:  Herbert W Virgin; John A Todd
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 3.  Have genomic discoveries in inflammatory bowel disease translated into clinical progress?

Authors:  Adam V Weizman; Mark S Silverberg
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 4.  Genomics and epigenomics of the human glycome.

Authors:  Vlatka Zoldoš; Mislav Novokmet; Ivona Bečeheli; Gordan Lauc
Journal:  Glycoconj J       Date:  2012-05-31       Impact factor: 2.916

5.  Presence of multiple independent effects in risk loci of common complex human diseases.

Authors:  Xiayi Ke
Journal:  Am J Hum Genet       Date:  2012-07-05       Impact factor: 11.025

6.  eQTL analysis links inflammatory bowel disease associated 1q21 locus to ECM1 gene.

Authors:  Katja Repnik; Uroš Potočnik
Journal:  J Appl Genet       Date:  2016-01-06       Impact factor: 3.240

Review 7.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

8.  Prevalence and Associations of Avascular Necrosis of the Hip in a Large Well-characterized Cohort of Patients With Inflammatory Bowel Disease.

Authors:  Vineet S Rolston; Anish V Patel; Thomas J Learch; Dalin Li; Dmitry Karayev; Chadwick Williams; Madhavi L Siddanthi; Stephan R Targan; Michael H Weisman; Dermot P B McGovern
Journal:  J Clin Rheumatol       Date:  2019-01       Impact factor: 3.517

Review 9.  Intestinal fucose as a mediator of host-microbe symbiosis.

Authors:  Joseph M Pickard; Alexander V Chervonsky
Journal:  J Immunol       Date:  2015-06-15       Impact factor: 5.422

Review 10.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.